FDG PET Is a Robust Tool for the Diagnosis of Spondylodiscitis
Authors:
- Panayiotis D. ZiakasPZPanayiotis D. Ziakas
- Loukia S. PoulouLPLoukia S. Poulou
- Petros KarsaliakosPKPetros Karsaliakos
- Loukas ThanosLTLoukas Thanos
- Eleftherios MylonakisEMEleftherios Mylonakis
- 1 April 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 39 (4) , 330-335
Abstract
Spondylodiscitis is a rare infectious entity that requires multimodal diagnostic procedures. We evaluated the diagnostic performance of 18F-FDG PET on suspected spondylodiscitis based on published literature. We searched the PubMed and EMBASE for pertinent studies up to July 2013. We implemented a patient-based meta-analysis of diagnostic data for FDG PET (the index test) against clinical, laboratory, and/or radiologic evidence of disease (the reference standard). A bivariate analysis was implemented to account for variability beyond the threshold effect. The individual patient data analysis was used to assess confounding factors that moderate diagnostic performance. Twelve studies provided the diagnostic data on FDG PET and spondylodiscitis, comprising 224 patients. The combined sensitivity across studies was 0.97 [95% confidence interval (CI), 0.83-1.00], the specificity was 0.88 (95% CI, 0.74-0.95), and the area under the curve was 0.98 (95% CI, 0.96-0.99). For prior probabilities greater than 0.50, the corresponding positive predictive value was 0.96 (0.93-0.98), and the negative predictive value was 0.85 (0.82-0.88). In the individual patient data analysis, metallic implants, dual PET/CT scanners and the addition of other imaging modalities to confirm disease were significant outcome moderators; only PET/CT remained significant in the adjusted analysis. PET/CT scanners improved the diagnostic performance, as opposed to the clinical data (age, sex, lesion site), which did not alter outcome. FDG PET is a robust diagnostic test when spondylodiscitis is suspected and is excellent for exclusion of infectious spondylodiscitis given its low likelihood ratio negative (<0.1). Importantly, this diagnostic test is unaffected by other confounders, including the presence of implants, when PET/CT is used.Keywords
This publication has 32 references indexed in Scilit:
- FDG-PET for detecting local tumor recurrence of ablated liver metastases: a diagnostic meta-analysisBiomarkers, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Spondylodiscitis: update on diagnosis and managementJournal of Antimicrobial Chemotherapy, 2010
- Expanding role of 18F-fluoro-d-deoxyglucose PET and PET/CT in spinal infectionsEuropean Spine Journal, 2010
- Clinically Proven Radiopharmaceuticals for Infection Imaging: Mechanisms and ApplicationsSeminars in Nuclear Medicine, 2009
- Spinal InfectionsClinical Orthopaedics and Related Research, 2006
- Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviewsJournal of Clinical Epidemiology, 2005
- Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary resultsEuropean Spine Journal, 2001
- A new MRI technique for imaging scoliosis in the sagittal planeEuropean Spine Journal, 2001
- FDG-PET zur Diagnostik und Verlaufskontrolle entzündlicher Prozesse: Erste Ergebnisse aus orthopädischer SichtZeitschrift für Orthopädie und ihre Grenzgebiete, 2000